Clients
The cannabis industry has experienced significant growth over the past decade thanks to shifting consumer sentiments, legislative victories, and a growing corporate sector. At the same time, governments have struggled to keep up with regulations to protect consumers—including the safety of those that aren’t consuming any cannabis. In the 1960s, alcohol breathalyzers became widely available […]
Silo Pharma Secures Patent that May be Used for Psychedelics Delivery Technology
Silo Pharma’s notice of allowance paves the way toward clinical trials for its psychedelics delivery platform using homing peptides. Silo Pharma Inc. (OTCQB: SILO), a development-stage biopharmaceutical company focused on the therapeutic potential of psychedelics, recently announced that the U.S. Patent Office issued a notice of allowance for its technology/method patent covering an isolated homing […]
Big Data, Acquisitions Point the Way for Plant-Based Medicines
How do you know if plant-based medicines are hitting the mainstream? One indicator might be when tobacco giant Philip Morris International makes a $1.45 billion offer to acquire Vectura, a firm focused on inhaled medicine formulations and devices. The move is part of PMI’s pivot away from harmful tobacco products and toward “respiratory drug delivery […]
Decibel to Announce Second Quarter Results on August 16
CALGARY, AB, Aug. 11, 2021 /PRNewswire/ – Decibel Cannabis Company Inc. (the “Company” or “Decibel”) (TSXV: DB) (OTCQB: DBCCF), a premium cannabis producer, is pleased to announce the Company will release its 2021 second quarter financial results and related management discussion and analysis on August 16, 2021 before markets open. About Decibel Decibel is uncompromising in the process and craftsmanship needed to […]
The psychedelic renaissance has taken the research community by storm, but psilocybin, DMT, MDMA, and other therapies remain in development. Ketamine is the only widely available psychedelic therapy that the FDA approves to treat depression and suicidal ideations. As a result, investors may want to start there for near-term opportunities. Let’s take a look at […]
VANCOUVER, British Columbia, July 22, 2021 (GLOBE NEWSWIRE) — KetamineOne Capital Limited (“Ketamine One” or the “Company”) (NEO: MEDI) (OTC: KONEF) (Frankfurt: MY0), a company focused on consolidating medical clinics and becoming a North American leader in mental health treatments, is pleased to highlight the continued success of the Health Canada-approved NeuroCatch Platform (“NeuroCatch”) in […]
Hempsana Signs Processing Agreement With New Leaf Canada
Hempsana Holdings Ltd. (the “ Company ” or “ Hempsana ”) is pleased to announce the Company has signed a processing agreement with New Leaf Canada Inc. ( “New Leaf” ) to process 2,000kg of hemp to produce full spectrum CBD crude for revenue of up to CAD $200,000. On July 20, 2021, the Company completed a processing agreement to process […]
Ketamine is Leading the Psychedelic Revolution: Here’s How to Invest
The FDA approval of Johnson & Johnson’s Spravato®—an esketamine nasal spray for treatment-resistant depression—marked the start of the psychedelic revolution. While ketamine was well-known as an anesthetic and party drug, the regulatory approval opened the door to treating the leading cause of disability worldwide—depression. Ketamine alleviates the symptoms of depression in a matter of hours, […]
Rising Cannabis Extractor Going Public Today
In the Canadian cannabis market, Cannabis 3.0 is finally starting to realize the sales potential many investors imagined back in 2019. That is when Canada legalized cannabis-derived products like oils, extracts, and edibles, and the thought was these new products would spur incredible growth in a somewhat flat industry that hadn’t been returning profits on […]
MedXtractor’s Reference Database Sets the Stage for SHAMAN & YMI
Artificial intelligence is already transforming many parts of our everyday lives. For example, Netflix recommends movies we’d enjoy, Facebook identifies friends in photos, and Alexa understands voice commands. Yet, despite these recent advances, most experts agree that AI is only starting to scratch the surface of what’s possible. According to Grand View Research, the global […]
MedXtractor Fills a Key Gap in Mental Health Treatments
According to the Lancet Commission, mental health disorders are on the rise in every country worldwide, and the resulting lost productivity will cost the global economy $16 trillion by 2030. Yet, despite nearly two billion people with mental illness each year, these conditions are routinely misdiagnosed and inadequately treated. MedXtractor Corp.’s (CSE: MXT) (OTC: […]
Data Analysis Yields Insights Into Medical Cannabis Use, Efficacy
Just about any industry benefits greatly from the proper use and evaluation of data. The tech giants of today are built mostly on data regarding their users, and advertisers rely on that data to more effectively target their efforts. Every major professional sport is undergoing an analytics revolution. Pharmaceutical companies use artificial intelligence (AI) to […]
Market Share vs. Market Cap in Canadian Cannabis
The adult-use cannabis market got off to a raging start before even one gram was sold. Many companies committed vast resources to greatly increase production capacity ahead of full legalization. Many of those companies achieved lofty valuations in the public capital market as a result. After about two and a half years, a look […]
Hempsana: An Emerging Leader in Cannabis 3.0
The cannabis movement began with the legalization of medical and adult-use cannabis in Canada and parts of the United States. With the Cannabis 2.0 revolution, cannabis producers expanded beyond flower to produce edibles, beverages, vapes, tinctures and other products while cannabidiol (CBD) became legal in many jurisdictions around the world. The next stage of […]
RYAH Group, Inc Publishes Report on Medical Cannabis Use for Pain
TORONTO, June 10, 2021 (GLOBE NEWSWIRE) — via InvestorWire — RYAH Group, Inc. (CSE:RYAH) (“RYAH” or the “Company”) is pleased to announce that its wholly owned subsidiary, RYAH Medtech Inc. (“RYAH Medtech”), has published a data report on use of medical cannabis among patients with pain conditions. The data report features insights into the use of cannabis […]
Ovation Science’s Proven Science, IP, and Royalty Model Protects Investors and the Company
If a company has developed very effective, transformative technology, it takes an investment into research and development and time. It also pays to protect it from copycats and pirates with patents. And if the company’s specialty is science and product development rather than in retail sales and marketing, a royalty- or license-based revenue model could […]
Englewood Cliffs, NJ, June 08, 2021 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (OTCQB: SILO) a development-stage biopharmaceutical company focused on the use of psychedelics as a therapeutic, is pleased to announce that it has entered into a Scientific Research Agreement (SRA) with the University of California San Francisco (UCSF). This SRA will leverage four other clinical […]
True Leaf Brands Inc. CEO Letter to Shareholders
Vernon, British Columbia–(Newsfile Corp. – June 8, 2021) – To True Leaf Brands Inc. (CSE: MJ) (OTC Pink: TRLFF) (FSE: TLAA) (“True Leaf” or the “Company”) shareholders, “True Leaf 2.0” has emerged from a challenging 2020 as a Company with a promising future ahead. We believe our restructuring last year allowed us to prepare and launch […]
Dispensaries Can Boost Cannabis Sales with Unique Topical Products
As the legal cannabis industry matures and expands, the goal of many companies is (and should be) to reach people who might not historically be cannabis consumers. According to a 2020 Gallup poll, about 12% of US adults say they smoke marijuana. This percentage has remained fairly steady over the past several years, even […]
BC’s First Craft Cannabis Hub Open to All Investors
British Columbia may be well-known for its legendary cannabis strains and connoisseur-level products, but licensed small-batch producers -known as ‘micro-cultivators’, have struggled to reach the same scale as licensed producers in the legal market. Many lack the resources to remain in compliance, and they are seeking service providers for quality assurance skills, packaging, pricing and […]
RYAH Medtech Expanding Internationally with Flurry of Deals
A sometimes overlooked aspect of the cannabis industry is the global potential for North American companies. To be sure, the United States and Canada represent the largest and most mature legal cannabis markets, and many companies are rightfully focused on them exclusively. But some companies are set up to not only capitalize on these […]
Gage Growth Corp. Impressing Both Consumers and Analysts
Gage Growth Corp. (CSE: GAGE) (OTC: GAEGF) went public in early April 2021, and with a month or two under its pubco belt analysts are taking a closer look at the company. Meanwhile, Gage’s focus on the high growth Michigan legal cannabis market, premium brands covering a wide range of product types, and a clean […]
Decibel Cannabis Co. Flourishes Amid Provincial Supply Reset
With financial results coming in for Q1 2021, there is a pattern emerging among Canadian Licensed Producers of cannabis. With a few exceptions, sales and revenue figures are significantly down across the board. Compared to the prior quarter, many companies are reporting sales decreased anywhere from 10% to upwards of 25% for the period. There […]
Ovation: Where Science, Medicine, and Cannabis Meet
With the quickly expanding legal cannabis market finding its legs after years of prohibition, there are several hurdles remaining before the plant and its cannabis-derived product offspring are fully accepted by mainstream society. First and foremost is, of course, full legalization. From that important step everything follows, from banking regulations to changes in incarceration […]
RYAH Medtech Inc. Ships Devices for Use in Pilot Study with CLINN Medical Center
NEW YORK, May 25, 2021 (GLOBE NEWSWIRE) — via InvestorWire — RYAH Group, Inc.’s (CSE:RYAH) (“RYAH” or the “Company”) wholly owned subsidiary, RYAH Medtech Inc. (“RYAH Medtech”), announces it has completed initial shipment of its proprietary Smart Dose-Measuring inhalers for use in a pilot study conducted by CLINN medical center in Milan, Italy. CLINN, the […]
NASDAQ-listed Enveric Acquires MagicMed to Bring Psychedelics Derivatives to Market
Enveric Biosciences (NASDAQ: ENVB), best-known for its pipeline of naturally occurring cannabinoid compounds, recently entered into a definitive agreement to acquire MagicMed Industries, a private biotechnology company focused on building a library of novel derivative psychedelic molecules with applications across multiple indications. The transaction broadens Enveric Bioscience’s focus into psychedelics and complements its existing pipeline […]
Cannabis Extractors May Present Less Risk Than Growers
ana One dynamic that led to the crash in the public markets for Canadian cannabis companies was the rush to build extensive cultivation capacity in anticipation of full legalization of the plant in 2018. Many millions of dollars were funneled into facilities across the country, accompanied by the anticipation of returns on those investments. For […]
Cybin Looks to Develop the Next Blockbuster Drugs
The pharmaceutical industry has struggled for years to develop effective psychiatric and neurological treatments. For example, many antidepressants and antipsychotics show only marginal efficacy in reducing symptoms compared to placebos over the short-term. The long-term use of many psychiatric drugs is also associated with adverse side-effects. Psychedelics are an exciting development in neuropsychiatry because of […]
True Leaf Empowers Micro-Cultivators to Usher in Craft Cannabis Era
Canada’s cannabis market is dominated by large cultivators and processors operating at scale. Of course, most of the industry’s largest companies are more focused on margins and volume, resulting in expensive low-to-mid quality cannabis, which could be part of the reason that the illegal market still accounts for about 60% of all cannabis sales nationwide. […]
Decibel Continues Growth in Key Products, Markets
The story of the cannabis industry has finally boiled down to its essence after years of hype- and story-driven investment. The fundamental question is now, as it should be: Who can sell their stuff and make money doing it? It is time for companies to show their hands, and the market decides who is bluffing. […]
Search CannabisFN
Press Coverage
Psychedelics Index
Top Videos
Matt Hawkins is the founder and managing principal of Cresco Capital Partners, LLC (“Cresco”), a private equity firm focused specifically on investing in the legalized cannabis industry. Since its inception in the summer of 2015, Cresco has made 14 investments out of its first fund and is currently raising this fund, Fund II. Prior to the […]
Matthew Nordgren is an ambitious executive, dedicated philanthropist, and accomplished athlete who brings a unique passion to creating strategic alliances. He has breadth and depth of experience in finance, corporate development, and capital sourcing, as well as in building highly motivated teams of skilled professionals. In 2005, Mr. Nordgren received his education at the University […]
Xphyto Therapeutics Corp. was created to bridge the gap between traditional cannabis-based medicine and modern scientific approaches to therapeutic validation.
Network Partners
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.
Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer
